Results 101 to 110 of about 2,519 (184)

Utilizzo di Idarucizumab [PDF]

, 2019
Utilizzo in Toscana di idarucizumab, antidoto di ...
Lombardi Niccolò, Crescioli Giada, Bettiol Alessandra, Vannacci Alfredo, Brilli Valentina, Mannaioni Guido, Fumagalli Stefano, Gini Rosa, Mazzaglia Giampiero   +8 more
openaire  

Dose requirements for idarucizumab reversal of dabigatran in a lethal porcine trauma model with continuous bleeding

, 2017
Idarucizumab is licensed for emergency reversal of dabigatran. A single 5 g dose is usually sufficient, but higher doses may sometimes be required and optimum dosing has not been defined.
Markus Honickel, Grottke, Oliver, Joanne van Ryn, Rossaint, Rolf, Rolf Rossaint, Spronk, Henri M., Stoppe, Christian, Spronk, H. M., Henri M. Spronk, Christian Stoppe, Honickel, Markus, Hugo ten Cate, Oliver Grottke, van Ryn, Joanne, Ten Cate, Hugo   +14 more
core   +1 more source

Idarucizumab in High-risk Thoracic Surgery

International Journal of Organ Transplantation Medicine, 2018
Direct oral anticoagulants have suggested a favorable profile compared with vitamin K antagonists. However, the lack of treatment to reverse the effect of direct oral anticoagulants has limited its use in some patients who require rapid reversal of ...
R L�pez Vilella, J Sanz S�nchez, I S�nchez L�zaro, E Marqu�s-Sul�, J Rueda Soriano, L Almenar Bonet   +5 more
doaj  

Anticoagulants: Updates on idarucizumab [PDF]

British Dental Journal, 2017
J S, Chandan, T, Thomas, H S, Baryah
openaire   +2 more sources

Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer

, 2017
Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a ...
C Hermans (13445205), S Eeckhoudt (13553860), T Duprez (13346010), A Peeters (9174206), G Turine (13553857)   +4 more
core  

Successful treatment of severe dabigatran intoxication with idarucizumab in a patient with acute kidney injury

, 2017
In the course of an uncomplicated sigmoidostomy a 63-year-old male who had severe comorbidity developed a critical bleeding due to dabigatran intoxication induced by acute kidney injury.
Bestle, Morten, Boesby, Lene, Poulsen, Christina Gjerlev   +2 more
core   +1 more source

The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays

, 2018
INTRODUCTION: The direct thrombin inhibitor dabigatran interferes with thrombophilia screening and with the diagnosis of hemostasis disorders that develop during treatment with the anticoagulant.
Debasse, M., Feyen, L., Vanlinthout, I., Schoeters, J., Vanassche, T., Peerlinck, K., Van Horenbeeck, I., Toelen, J., Jacquemin, M., Verhamme, P., T. Vanassche, P. Verhamme, J. Toelen, I. Van Horenbeeck, I. Vanlinthout, M. Jacquemin, K. Peerlinck, L. Feyen, M. Debasse, J. Schoeters   +19 more
core   +1 more source

Idarucizumab Dosing in Kidney Failure [PDF]

American Journal of Kidney Diseases, 2018
Luke Yip, Jou-Fang Deng
openaire   +2 more sources

Erratum: Updates on idarucizumab [PDF]

British Dental Journal, 2017
openaire   +2 more sources

Dabigatran Reversal with Idarucizumab

New England Journal of Medicine, 2017
Pollack, Charles V., Reilly, Paul A, Weitz, Jeffrey I   +2 more
openaire   +6 more sources